Word

LYMPHOQUANT

Status

Registered

Status Code

700

Status Date

Tuesday, June 1, 2021

Serial Number

87588377

Registration Number

6373233

Registration Date

Tuesday, June 1, 2021

Mark Type

4000

Filing Date

Tuesday, August 29, 2017

Published for Opposition

Tuesday, January 30, 2018

Trademark Owner History

INVIVOSCRIBE, INC. - Original Registrant
Invivoscribe Technologies, Inc. - Owner At Publication

Classifications

1 Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use

5 Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids

42 DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

44 DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

LYMPH QUANT

Trademark Events

Jun 1, 2021

Registered-Principal Register

Apr 28, 2021

Notice Of Acceptance Of Statement Of Use E-Mailed

Apr 27, 2021

Allowed Principal Register - Sou Accepted

Apr 26, 2021

Statement Of Use Processing Complete

Mar 25, 2021

Use Amendment Filed

Apr 26, 2021

Case Assigned To Intent To Use Paralegal

Mar 25, 2021

Teas Statement Of Use Received

Oct 2, 2020

Notice Of Approval Of Extension Request E-Mailed

Oct 1, 2020

Extension 5 Granted

Sep 24, 2020

Extension 5 Filed

Sep 30, 2020

Case Assigned To Intent To Use Paralegal

Sep 24, 2020

Teas Extension Received

Mar 27, 2020

Notice Of Approval Of Extension Request E-Mailed

Mar 25, 2020

Extension 4 Granted

Mar 25, 2020

Extension 4 Filed

Mar 25, 2020

Teas Extension Received

Sep 28, 2019

Notice Of Approval Of Extension Request E-Mailed

Sep 26, 2019

Extension 3 Granted

Sep 26, 2019

Extension 3 Filed

Sep 26, 2019

Teas Extension Received

Mar 23, 2019

Notice Of Approval Of Extension Request E-Mailed

Mar 21, 2019

Extension 2 Granted

Mar 21, 2019

Extension 2 Filed

Mar 21, 2019

Teas Extension Received

Sep 29, 2018

Notice Of Approval Of Extension Request E-Mailed

Sep 27, 2018

Extension 1 Granted

Sep 27, 2018

Extension 1 Filed

Sep 27, 2018

Teas Extension Received

Sep 5, 2018

Automatic Update Of Assignment Of Ownership

Mar 28, 2018

Applicant/Correspondence Changes (Non-Responsive) Entered

Mar 28, 2018

Teas Change Of Owner Address Received

Mar 27, 2018

Noa E-Mailed - Sou Required From Applicant

Jan 30, 2018

Official Gazette Publication Confirmation E-Mailed

Jan 30, 2018

Published For Opposition

Jan 10, 2018

Notification Of Notice Of Publication E-Mailed

Dec 26, 2017

Assigned To Lie

Dec 5, 2017

Approved For Pub - Principal Register

Dec 5, 2017

Examiner's Amendment Entered

Dec 5, 2017

Notification Of Examiners Amendment E-Mailed

Dec 5, 2017

Examiners Amendment E-Mailed

Dec 5, 2017

Examiners Amendment -Written

Dec 4, 2017

Assigned To Examiner

Sep 6, 2017

New Application Office Supplied Data Entered In Tram

Sep 1, 2017

New Application Entered In Tram